The table below shows Twist Bioscience Corp's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q4 2025
Q4 2024
Q4 2023
Q4 2022
Q4 2021
Q4 2020
Operating cash flow
-$24.81M
-$21.43M
-$22.97M
-$54.07M
-$46.65M
-$24.93M
Capital expenditure
$9.97M
$2.27M
$1.51M
$11.82M
$12.78M
$3.63M
Investing cash flow
-$9.93M
-$1.54M
$4.17M
-$6.97M
-$226.58M
-$45.92M
Dividends paid
-
-
-
TWST operating cash flow (10-K history)
Twist Bioscience Corp reported operating cash flow of -$47.63M for fiscal year 2025. That is up 25.7% from -$64.09M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow grew from -$51.30M (FY 2017) to -$47.63M. Figures come from the company's audited annual reports as filed with the SEC.
